FDA Issues New Manual for Prioritizing Site Inspections

Drug Industry Daily
A A
The FDA Wednesday released a new manual of policies and procedures (MAPP) outlining how it prioritizes manufacturing facilities for routine CGMP surveillance inspections.

To View This Article:

Login

Subscribe To Drug Industry Daily